Ocular system

You can perform (jiiatiLum m cell an ical calculations on a part of a rn o I ocular system, such as a solute, vh ilc using rn o I ocular mcch an -ics for Lh c rest of th o system, such as the solvon t siirroiindin g th o solute. I h is boun dary tech n itjue is avaliable in HyperCbom for all quantum mechanical methods. It is somewhat loss com ploto with ah initio calculations than with som i-cmpirical calculations, however, With ah nii/jo calculation s the boundary must occur between molecules rather than in side a molecule. 

No ocular products for systemic therapy are commercially available, but research is under way on ocular systems for the systemic deUvery of therapeutic agents such as insulin (53). 

GLAUCOMA When a cholinergic drug is used to treat glaucoma, die nurse checks the eye and die area around die eye daily for evidence of redness, inflammation, and excessive secretions, particularly if die ocular system is used. If secretions are present around die eye, the nurse removes them with a cotton ball or gauze soaked in normal saline or other cleansing solution recommended by die primary health care provider. 

Pilocarpine Ocular System. If the pilocarpine ocular system is prescribed for the hospitalized patient, die nurse checks die cheek and eye area several times a day because die system can become displaced from die eye. 

Most patients are usually aware of displacement of the pilocarpine ocular system, but some patients, the elderly in particular, may not realize that the system has come out of the eye. If displacement does occur, the nurse inserts a new astern and informs the primary health care provider of the problem. 

On occasion, patients cannot insert die system by diemselves or cannot retain die system in die eye for the required time. When tiiis occurs, the nurse notifies the primary healtii care provider because die ocular system should remain in place until it is time for it to be changed. The nurse changes die pilocarpine ocular system every 7 days unless die primary healdi care provider orders odierwise (Display 24-1). 

If patients have a problem retaining die system, placing die system in die upper conjunctival cul-de-sac is preferable The nurse can manipulate die system from die lower to die upper conjunctival cul-de-sac using gentie massage through die eyelid. The nurse contacts die primary healdi care provider if die symptoms of glaucoma increase, if die patient is unable to retain the ocular system, or if redness, eye irritation, or excessive secretions are noted. 

PI LOCARPIN E OCULAR SYSTEM. If tlie pilocarpine ocular system is prescribed, the primary health care provider must evaluate the patient s ability to insert and remove tlie system. A package insert is provided with tlie system... 

Mr. Johnson, age 78 years, has glaucoma and is prescribed the pilocarpine ocular system. On a visit to the outpatient clinic, Mr. Johnson tells you that he is having problems retaining the ocular system. You notice that his right eye is very red and inflamed. Determine how you can investigate this problem further with Mr. Johnson. Provide suggestions that will help Mr. Johnson to retain the system. 

Routine gross and histopathological examinations revealed no treatment-related effects on the ocular systems of dogs exposed to 0.03, 0.1, or 0.3 mg/kg/day methyl parathion in the diet for 1 year (Suba 1981). 

No studies were located regarding cardiovascular, hematological musculoskeletal, renal, or dermal/ocular systemic effects in humans or animals following oral exposure to 1,2-diphenylhydrazine. 

No studies were located regarding effects on the respiratory, cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dermal/ocular systems in humans following inhalation exposure to chlorobenzene. 

There are over 40 lysosomal storage disorders (LSDs) characterized by the specific enzyme deficiency and accumulated substrate. Pathologies associated with LSDs are multisystemic and variable including CNS, skeletal, cardiovascular, renal, and ocular system involvement. The aggregate incidence is estimated to approach 1 in 7000 live births (Ellinwood et al., 2004). Inheritance for LSDs is primarily autosomal recessive with the exception of two X-linked diseases (Fabry and mucopolysaccharidosis (MPS) II). Treatment for LSDs relies on providing functional enzyme to the lysosomes of affected cells and has traditionally been confined to bone marrow transplantation, and enzyme replacement therapy (ERT). 

The eye is a unique structure, because several of its fluids and tissues—tear film, cornea, aqueous humor, lens, and vitreous humor—are almost completely transparent. These components of the ocular system have no direct blood supply in the healthy state. Each can be considered a separate chamber or compartment. A compartment is defined here as a region of tissue or fluid through which a drug can diffuse and equihbrate with relative freedom. Each compartment is generally separated by a barrier from other compartments, so that flow between adjacent compartments requires more time than does diffusion within each compartment. 

Hydroxypropyl cellulose ocular system Drug product... 

Finne U, Salivirta J, Urtti A. Sodium acetate improves the ocular/ systemic absorption ratio of timolol applied ocularly in monoisopropyl PVM-MA matrices. Int J Pharm 1991 75 Rl—R4. 

I.N. Flamarique, K. Ovaska, T.M. Davis (2000). UV-B induced damage to the skin and ocular system of amphibians. Biol. Bull., 199,187-188. 

Place of application vascular system (infusion) subcutis (implantation skin (transdermal) ocular systems uterin systems ... 

Stem, J. A., Dunham, D.N. (1990). The ocular system. In J. T. Cacioppo, L. G. lassiaary (Eds.), Principles of psychophysiology Physical, social and inferential aspects pp. 513-553). Cambridge Cambridge University Press. 

Prosthetic eyes are traditionally made from hard materials such as acrylic, gold, ceramics, and glass. When an individual loses an eye, it is replaced with a temporary implant that is positioned toward the back of the eye socket to allow proper room for the prosthetic eye. With the use of an impression, a wax model is made, followed by a mold for casting the prosthetic eye. Components of the eye, such as the pupil and the iris, are painted on a round plastic base and eventually inserted on the prosthetic eye. Some prosthetic eyes can even be designed to allow for the attachment of eye muscles. One of the trends in design is to develop an ocular system that allows for more natural movement. 

Ocular systems (Figure 7.5b) with application in the lower ophthalmic conjunctival sac for the controlled release of ciprofloxacin (pre- or post-operative treatment of topical infections, as well as conjimctivitis) were obtained from polyvinyl alcohol and sodium carboxymethylcellulose linking the two polymers by an esterification reaction between the hydroxyl groups of the polyvinyl alcohol and carboxyl groups of carboxy-methyl cellulose [47]. Membranes were obtained by the incorporation of the antibiotic into the polymer solution with the addition of glycerol as a plasticizer (in order to ensure the flexibility of the membrane). The advantage of using these polymers comes from their biocompatibility and from the fact that they are water soluble as the controlled release occms, the membrane is dissolved by the tear bed at 35"C temperature. 

The prodrug approach 2 has been resorted to in some instances to improve the ocular/systemic absorption ratio, as in the case of dipivalylepinephrine (Dipivefrin, DPE), a lipophilic prodrug of epinephrine (EP), an antiglaucoma topical drug. The majority of topical EP, administered as a 2% solution, enters the systemic circulation, as a result of systemic absorption through the nasal mucosa, and has been reported many times to produce systemic a- and p-adrenergic symptoms. DPE has no apparent systemic effect, because the enzymatic release of EP occurs most efficiently in the cornea, which is better penetrated by the more lipophilic DPE. The rationale for the realization of prodrugs is illustrated in Fig. 8. 

---